Related Articles
Engineered human mesenchymal stem cells for neuroblastoma therapeutics
Vasoactive intestinal peptide decreases MYCN expression and synergizes with retinoic acid in a human MYCN-amplified neuroblastoma cell line
The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide
Fenretinide targeting of human colon cancer sphere cells through cell cycle regulation and stress‑responsive activities
Inhibition of angiopoietin 2 attenuates lumen formation of tumour-associated vessels in vivo